Uso de palivizumab en el control de un brote de virus respiratorio sincicial en una unidad de cuidado intensivo neonatal
Fernanda Cofré1, Patricia Vernal2, Susana Mendoza2, Katherine Martinez3, Agustina Gonzalez2
1 Pediatra Infectólogo, Hospital Roberto del Río.
2 Neonatólogo, Hospital San José.
3 Matrona, Hospital San José.
Resumen |Abstract | Texto completo | Descargar cuerpo en pdf |
Respiratory syncytial virus (RSV) infection is the leading cause of morbidity in infants. High risk group presents serious infections, particularly preterm birth. An RSV outbreak occurred in the neonatal intensive care and we described the control measurements taken, including the use of palivizumab
Key words: palivizumab, preterm birth, neonatal intensive care unit. |
